"This award speaks directly to the caliber of individuals that make up our high-performing teams," said John Potthoff, INC Research COO. "Jen’s initiative in participating in this program and developing herself professionally are an asset to INC Research and we are very proud to see her receive this recognition."

The US Clinical Researcher of the Year program is a competition for clinical researchers from pharmaceutical companies, CROs and investigator sites, and recognizes rewards and celebrates excellence in clinical research. It was launched in 2009 to raise the profile and importance of clinical research in the US by recognizing outstanding individual clinical researchers and research teams.

"Participating in the Clinical Researcher of the Year competition has been a really positive experience," said INC Research CRA Jen Catena Davis. "The different stages of the competition presented exercises that really made me think deeply about my job and the purpose it serves. I really enjoyed the opportunity to think about the essentials of my job objectively, without influence from any sponsor’s specific needs or preferences. I think that participating in this process has made me a better monitor, site manager, and
team lead."

INC Research is a privately held, therapeutically focused global CRO with deep expertise in managing global Phase I through Phase IV clinical development programs. INC Research employs more than 2,000 people in 40 countries worldwide. The full-service CRO was recently ranked 10th on the list of Preferred CROs, an annual survey conducted by William Blair and was number 10 on the Scrip Clinical Research 25 list based on 2009 revenues.